Juntendo University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Juntendo University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011860
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Juntendo University (Juntendo) is a healthcare service provider that offers medical education and research services. The institute offers medical education, practices and healthcare services which include consultation, nursing, emergency room, and others. Its services comprise radiology, sport activity and wellness center, rehabilitation center, hospital wards, health care coordination room, counseling center and patient education classes, and shops. Juntendo’s radiology department provide MRI, CT, angiography and LINAC radiation therapy services. The institute offers education and training programs in the fields of health and sports science, nursing health care and sciences, liberal arts, and medicine. Juntendo is headquartered in Tokyo, Japan.

Juntendo University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Juntendo University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Juntendo University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Juntendo University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Juntendo University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Juntendo University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Juntendo University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Oncolys BioPharma Enters into Research Agreement with Juntendo University 10
Heptares Therapeutics Enters into Research Agreement with Juntendo University 11
Gene Techno Science Enters into Research Agreement with Juntendo University 12
Juntendo University – Key Competitors 13
Juntendo University – Key Employees 14
Juntendo University – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Jan 11, 2017: Juntendo University research: Stem cells provide sound in vitro models for deafness 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Juntendo University, Pharmaceuticals & Healthcare, Key Facts 2
Juntendo University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Juntendo University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Juntendo University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Juntendo University, Deals By Therapy Area, 2011 to YTD 2017 8
Juntendo University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Oncolys BioPharma Enters into Research Agreement with Juntendo University 10
Heptares Therapeutics Enters into Research Agreement with Juntendo University 11
Gene Techno Science Enters into Research Agreement with Juntendo University 12
Juntendo University, Key Competitors 13
Juntendo University, Key Employees 14
Juntendo University, Subsidiaries 15

★海外企業調査レポート[Juntendo University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Capstone Turbine Corp (CPST):電力:M&Aディール及び事業提携情報
    Summary Capstone Turbine Corp (CPST) is an energy company. It develops, manufactures, markets, and services microturbine technology solutions and power generation systems. The company integrates air bearing technology, advanced combustion technology, and power electronics to form efficient and ultra …
  • Raia Drogasil SA:企業の戦略・SWOT・財務分析
    Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report Summary Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sagemcom SAS:企業の戦略的SWOT分析
    Sagemcom SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NovAliX SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary NovAliX SAS (NovAliX) is a contract research organization that offers outsourcing and insourcing research services for drug discovery. The organization provides chemical biology services such as chemistry, biophysics, drug discovery and protein purification services. Its biophysics services …
  • Eurus Energy America Corp:電力:M&Aディール及び事業提携情報
    Summary Eurus Energy America Corp (Eurus Energy) a subsidiary of Eurus Energy Holdings Corp, is a renewable energy company that develops wind and solar energy projects. The company provides wind project services including land and construction, data collection, operation and maintenance services. It …
  • Damas International Ltd:企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Basin Electric Power Cooperative:企業の戦略・SWOT・財務分析
    Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report Summary Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Euroclear Plc:企業の戦略・SWOT・財務分析
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nuo Therapeutics Inc (AURX):企業の財務・戦略的SWOT分析
    Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • UIL Energy Ltd (UIL):石油・ガス:M&Aディール及び事業提携情報
    Summary UIL Energy Ltd (UIL Energy) is an oil and gas company. The company provides business activities such as exploration for reserves of both conventional and unconventional oil and natural gas plays in proven hydrocarbon basins in Western Australia. It offers portfolio such as gas and liquids th …
  • Amicus Therapeutics Inc (FOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lea …
  • Quilvest Wealth Management:企業の戦略・SWOT・財務分析
    Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sekisui Chemical Co Ltd (4204):企業の財務・戦略的SWOT分析
    Sekisui Chemical Co Ltd (4204) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Elos Medtech AB (ELOS B):医療機器:M&Aディール及び事業提携情報
    Summary Elos Medtech AB (Elos Medtech) is a partner in development and manufacturer of medical devices and components. The company’s products include dental and orthopedic implants and instruments. It offers diagnostic devices used in the treatment of diabetes, neurosurgery, heart surgery and hearin …
  • Verbund AG (VER)-エネルギー分野:企業M&A・提携分析
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • Greencore Group Plc:戦略・SWOT・企業財務分析
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TriVascular Inc:製品パイプライン分析
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • Molecular Partners AG (MOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • CardioGenics Inc:企業の製品パイプライン分析2018
    Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company’s products include QL care analyzer, immunoassay tests, and paramagnetic beads, among ot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆